This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why You Should Retain Glaukos (GKOS) Stock for Now
by Zacks Equity Research
Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.
Freeport (FCX) Starts Commissioning of New Indonesian Smelter
by Zacks Equity Research
Freeport (FCX) anticipates that the smelter will begin producing copper cathodes in the following months and that it will reach full ramp-up by the end of 2024.
DuPont (DD) to Feature Kalrez Solutions at SEMICON West 2024
by Zacks Equity Research
DuPont's (DD) Kalrez perfluoroelastomer parts portfolio comprises O-rings, custom-designed components and bonded parts that incorporate metals, glass, ceramics and fibers.
Avantor (AVTR) Launches Solutions for Gene Therapy Harvest
by Zacks Equity Research
Avantor's (AVTR) solutions are intended to provide gene therapy manufacturers with sustainable and efficient alternatives to traditional methods, thus improving viral particle harvest and quality
Masimo's (MASI) WI Sport Wearable Gets a New Powerful Feature
by Zacks Equity Research
Masimo (MASI) announces Sleep Halo, a new feature for its Masimo W1 Sport advanced health tracking wearable.
GE Healthcare (GEHC) Enters Partnership to Boost MRI Technology
by Zacks Equity Research
GE Healthcare's (GEHC) alliance is likely to establish an Innovative MRI Research and Development center to advance MRI innovation and patient care
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
by Zacks Equity Research
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
Nexa Resources (NEXA) Sells Morro Agudo Complex to Casa Verde
by Zacks Equity Research
Nexa Resources (NEXA) sells its Morro Agudo Complex to optimize its portfolio.
B2Gold (BTG) Inks Deal to Buy 9.99% Stake in Prospector Metals
by Zacks Equity Research
B2Gold (BTG) to buy 5.6 million shares of Prospector Metals and become part of its technical committee.
Air Liquide's (AIQUY) Transformation Plan to Drive Efficiency
by Zacks Equity Research
Air Liquide's (AIQUY) strong business model and successful implementation of its ADVANCE strategic plan have put the company in on a solid footing.
PacBio (PACB) and Form Bio to Boost AAV Industry Development
by Zacks Equity Research
PacBio (PACB) and Form Bio collaborate to form an expert AAV Working Group to introduce essential tools for AAV development and research professionals.
H.B. Fuller (FUL) Q2 Earnings and Sales Beats Estimates
by Zacks Equity Research
H.B. Fuller's (FUL) second-quarter earnings and sales top estimates on higher gross margins and volumes.
Merit Medical (MMSI) Hits 52-Week High: What's Aiding It?
by Zacks Equity Research
Investors are optimistic about Merit Medical's (MMSI) strong product portfolio.
CalMaine Foods (CALM) Acquires ISE America Assets for $110M
by Zacks Equity Research
CalMaine Foods (CALM) buys assets of ISE to boost market reach in the Northeast and Mid-Atlantic states.
DOW & Fiori Team Up to Advance Sustainable Vehicle Recycling
by Zacks Equity Research
The Fiori Group and DOW MobilityScience teams will collaborate openly to produce a valuable prototype for recycling EOL vehicle parts and materials.
Here's Why You Should Buy Axalta Coating (AXTA) Stock Now
by Zacks Equity Research
Axalta Coating (AXTA) looks promising based on its robust Q1 results and the acquisition of The CoverFlexx Group.
Masimo (MASI), Cleveland Clinic Unite to Enhance Patient Care
by Zacks Equity Research
Masimo (MASI) collaborates with Cleveland Clinic to boost patient care by combining its Hospital Automation platform with the latter's central patient monitoring platforms.
Westlake's (WLK) Subsidiary Invests in Blackhorn Ventures
by Zacks Equity Research
Westlake's (WLK) action builds on the company's commitment to contributing to a more sustainable future through continual development of its own manufacturing as well as strategic investments.
BD's (BDX) New Research Tool to Aid Single-Cell Analysis
by Zacks Equity Research
BD (BDX) announces the commercial launch of its new single-cell research tool, BD Rhapsody ATAC-Seq Assay, to help researchers understand DNA regulation.
Glaukos (GKOS) Reaches 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.
Amerigo (ARREF) Affirms 2024 Guidance Despite Heavy Rains
by Zacks Equity Research
Amerigo (ARREF) anticipates heavy rains in Chile to impact its copper output by 1 million pounds.
Trinseo (TSE) Launches PMMA Depolymerization Facility in Italy
by Zacks Equity Research
Trinseo (TSE) opens a PMMA depolymerization facility in Italy, advancing sustainable recycling technology.
Element Solutions (ESI) Rallies 15% in 6 Months: Here's Why
by Zacks Equity Research
Element Solutions' (ESI) performance in the past six months is driven by strong performance and raised financial guidance for 2024.
BASF (BASFY) & Vattenfall Partner Vestas for Wind Turbines
by Zacks Equity Research
Vattenfall, BASF (BASFY) and Vestas intend to swiftly expand wind projects and decarbonize the European energy market.
Air Products (APD) Commences Expansion at Missouri Facility
by Zacks Equity Research
The new manufacturing facility by Air Products (APD) is set to start production by the end of 2025, with the addition of 30 full-time workers.